TOLLIP and non-small cell lung carcinoma: CCK-8 experiment indicated that upregulating miR-3124-5p significantly improved the proliferation of NSCLC cells (increased 0.4-fold (A549 and HCC827)), and the overexpression of TOLLIP reversed these effects (Fig. 6A).